Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras

Transplantation

Volumn 88, Issue 5, 2009, Pages 631-639

  De Jager, Saskia C A ^a   Canté Barrett, Kirsten ^b   Bot, Lize ^a   Husberg, Cathrine ^c,d   Van Puijvelde, Gijs H ^a   Van Santbrink, Peter J ^a   Yndestad, Arne ^e   Van Den Oever, Jessica M E ^b   Kuiper, Johan ^a   Van Berkel, Theo J C ^a   Lipp, Martin ^f   Zwaginga, Jaap Jan ^b   Fibbe, Wim E ^b   Aukrust, Pål ^e,g   Biessen, Erik A L ^a,h  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemokine receptor; Graft versus host disease; Memory t cell; Regulatory t cell

Indexed keywords

CHEMOKINE RECEPTOR CCR7; L SELECTIN; CCR7 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CCR7 DEFICIENCY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; ISOGRAFT; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHIMERA; GRAFT VS HOST DISEASE; IMMUNOLOGIC MEMORY; L-SELECTIN; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CCR7; T-LYMPHOCYTES;

EID: 70349567380     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b241df     Document Type: Article

References (38)

1. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765.
2. Voogt PJ, Goulmy E, Fibbe WE, et al. Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. J Clin Invest 1988; 82: 906.
3. 3. Voogt PJ, Goulmy E, Veenhof WF, et al. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med 1988; 168: 2337. (Pubitemid 19020909)
4. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004; 125: 435.
5. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Rev 2006; 20: 15.
6. Beschorner WE, Tutschka PJ, Santos GW. Chronic graft-versus-host disease in the rat radiation chimera. I. Clinical features, hematology, histology, and immunopathology in long-term chimeras. Transplantation 1982; 33: 393.
7. Tutschka PJ, Teasdall R, Beschorner WE, et al. Chronic graft-versushost disease in the rat radiation chimera. II. Immunological evaluation in long-term chimeras. Transplantation 1982; 34: 289.
8. Hathaway WE, Githens JH, Blackburn WR, et al. Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease. N Engl J Med 1965; 273: 953.
9. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340.
10. Hess A, Thoburn C, Chen W, et al. Autoreactive T-cell subsets in acute and chronic syngeneic graft-versus-host disease. Transplant Proc 2001; 33: 1754.
11. Kansu E. The pathophysiology of chronic graft-versus-host disease, Int J Hematol 2004; 79: 209.
12. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, et al. Leukocyte migration and graft-versus-host disease. Blood 2005; 105: 4191.
13. Rao AR, Quinones MP, Garavito E, et al. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-hostdisease. J Immunol 2003; 171: 4875.
14. Terwey TH, Kim TD, Kochman AA, et al. CCR2 is required for CD8 induced graft-versus-host disease. Blood 2005; 106: 3322.
15. 15. Gunn MD, Kyuwa S, Tarn C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189: 451. (Pubitemid 29187367)
16. Lo JC, Chin RK, Lee Y, et al. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues.; J Clin Invest 2003; 112: 1495.
17. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 2005; 6: 895.
18. Debes GF, Arnold CN, Young AJ, et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 2005; 6: 889.
19. 19. Misslitz A, Pabst O, Hintzen G, et al. Thymic T cell development and progenitor localization depend on CCR7. J Exp Med 2004; 200: 481. (Pubitemid 39121905)
20. Ueno T, Saito F, Gray DH, et al. CCR7 signals are essential for cortex-medulla migration of developing thymocytes. J Exp Med 2004; 200: 493.
21. Kurobe H, Liu C, Ueno T, et al. CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. Immunity 2006; 24: 165.
22. Davalos-Misslitz AC, Worbs T, Willenzon S, et al. Impaired responsiveness to T-cell receptor stimulation and defective negative selection of thymocytes in CCR7-deflcient mice. Blood 2007; 110: 4351.
23. 23. Beckmann. JH, Yan S, Luhrs H, et al. Prolongation of allograft survival in ccr7-deficient mice. Transplantation 2004; 77: 1809. (Pubitemid 38822201)
24. 24. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23. (Pubitemid 29468627)
25. D'Asaro M, Dieli F, Caccamo N, et al. Increase of CCR7- CD45RA+ CD8 T cells (T(EMRA) ) in chronic graft-versus-host disease. Leukemia 2006; 20: 545.
26. Yamashita K, Choi U, Woltz PC, et al. Severe chronic graft-versushost disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells. Blood 2004; 103: 3986.
27. Fu S, Yopp AC, Mao X, et al. CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004; 4: 65.
28. Mackay CR, von Andrian UH. Immunology. Memory T cells-Local heroes in the struggle for immunity. Science 2001; 291: 2323.
29. 29. Sallusto F, Kremmer E, Palermo B, et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999; 29: 2037. (Pubitemid 29265560)
30. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708.
31. 31. Sondel PM, Buhtoiarov IN, DeSantes K. Pleasant memories: Remembering immune protection while forgetting about graft-versus-host disease. J Clin Invest 2003; 112: 25. (Pubitemid 38056371)
32. Schneider MA, Meingassner JG, Lipp M, et al. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 2007; 204: 735.
33. Ato M, Maroof A, Zubairi S, et al. Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J Immunol 2006; 176: 5486.
34. Jang MH, Sougawa N, Tanaka T, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol 2006; 176: 803.
35. 35. Sasaki M, Hasegawa H, Kohno M, et al. Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21 ) prevents the development of chronic graft-versus-host disease in mice. J Immunol 2003; 170: 588. (Pubitemid 36026187)
36. 36. Ott TR, Lio FM, Olshefski D, et al. The N-terminal domain of CCL21 reconstitutes high, affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19. Biochem Biophys Res Commun 2006; 348: 1089. (Pubitemid 44233526)
37. Yakoub-Agha I, Saule P, Depil S, et al. A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006; 20: 1557.
38. 38. Kahlmann D, Davalos-Misslitz AC, Ohl L, et al. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis. BMC Genet 2007; 8: 33. (Pubitemid 47055083)